Babu, Manju
Rao, Rajas M.
Babu, Anju
Jerom, Jenat Pazheparambil
Gogoi, Anaekshi
Singh, Nikhil
Seshadri, Meenakshi
Ray, Animikh
Shelley, Bhaskara P.
Datta, Arnab https://orcid.org/0000-0002-9220-7812
Funding for this research was provided by:
Indian Council of Medical Research (BMI/11(67)/2022, BMI/11(67)/2022)
Yenepoya University (YU/Seed Grant/140-2023, YU/Seed Grant/092-2020)
Science and Engineering Research Board (SRG/2021/001357, SRG/2021/001357)
Article History
Received: 31 January 2024
Accepted: 23 September 2024
First Online: 1 October 2024
Change Date: 12 February 2025
Change Type: Update
Change Details: The original online version of this article was revised: The Figure 2, specifically for the representative images of the DCFDA assay of N2a cells (i.e., Figure 2C), the authors mistakenly included the image for the 50 µM NAR condition in the panel representing the 50 µM EDV condition.
Change Date: 11 February 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s12035-025-04742-7
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable.
: Not applicable.
: The authors declare no competing interests.